 The primary objective is to evaluate clinical effectiveness of transvaginal repair with Xenform against traditional native tissue repair in women surgically treated for anterior andor apical pelvic organ prolapse. Secondary objectives are to evaluate Xenform-related complications and subject reported outcomes. 